Lyra Therapeutics Q2 EPS $(0.43) Up From $(0.85) YoY

Lyra Therapeutics (NASDAQ:LYRA) reported quarterly losses of $(0.43) per share. This is a 49.41 percent increase over losses of $(0.85) per share from the same period last year.

Lyra Therapeutics (NASDAQ:LYRA) reported quarterly losses of $(0.43) per share. This is a 49.41 percent increase over losses of $(0.85) per share from the same period last year.

Total
0
Shares
Related Posts
Read More

Canadian Grain Shippers, Railroads Brace For Lower Grain Volumes

Canadian grain shippers expect rail service to match demand this crop year, although lingering service issues from summer wildfires plus broader network capacity concerns are also on their minds. Grain stakeholders anticipate lower volumes this crop year, which runs from Aug. 1 to July 31, 2022, as this summer's drought in western Canada will likely lower crop volumes. 

CNI